Patents by Inventor Noam Levaot

Noam Levaot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treatment of bone associated diseases
    Patent number: 11976099
    Abstract: Mutant M-CSF protein, comprising ?v?3 integrin binding motif and pharmaceutical compositions comprising same, are provided. Further, use of the composition for the treatment and or prevention of diseases associated with increased bone resorption are provided.
    Type: Grant
    Filed: August 4, 2021
    Date of Patent: May 7, 2024
    Assignees: THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD., B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY
    Inventors: Niv Papo, Noam Levaot, Yuval Zur, Lior Rosenfeld
  • COMPOSITIONS AND METHODS FOR TREATMENT OF BONE ASSOCIATED DISEASES
    Publication number: 20210403514
    Abstract: Mutant M-CSF protein, comprising ?v?3 integrin binding motif and pharmaceutical compositions comprising same, are provided. Further, use of the composition for the treatment and or prevention of diseases associated with increased bone resorption are provided.
    Type: Application
    Filed: August 4, 2021
    Publication date: December 30, 2021
    Applicants: THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD., B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY
    Inventors: Niv PAPO, Noam LEVAOT, Yuval ZUR, Lior ROSENFELD
  • Compositions and methods for treatment of bone associated diseases
    Patent number: 11098091
    Abstract: Mutant M-CSF protein, comprising ?v?3 integrin binding motif and pharmaceutical compositions comprising same, are provided. Further, use of the composition for the treatment and or prevention of diseases associated with increased bone resorption are provided.
    Type: Grant
    Filed: August 17, 2017
    Date of Patent: August 24, 2021
    Assignees: THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD., B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY
    Inventors: Niv Papo, Noam Levaot, Yuval Zur, Lior Rosenfeld
  • COMPOSITIONS AND METHODS FOR TREATMENT OF BONE ASSOCIATED DISEASES
    Publication number: 20190248845
    Abstract: Mutant M-CSF protein, comprising ?v?3 integrin binding motif and pharmaceutical compositions comprising same, are provided. Further, use of the composition for the treatment and or prevention of diseases associated with increased bone resorption are provided.
    Type: Application
    Filed: August 17, 2017
    Publication date: August 15, 2019
    Inventors: Niv PAPO, Noam LEVAOT
  • UNIVERSAL TARGET SEQUENCES FOR siRNA GENE SILENCING
    Publication number: 20080182813
    Abstract: The present invention provides a method for the production of a small interference RNA (siRNA) molecules for silencing the expression of a specific gene having AAUAAA as a polyadenylation signal site sequence. The method includes: a) identifying an oligonucleotide sequence of the specific gene, wherein the oligonucleotide sequence is about 15 to about 40 nucleotides in length and comprises (i) the polyadenylation signal site sequence and (ii) unique non-coding sequences flanking the polyadenylation signal site; and b) synthesizing oligonucleotide molecules having the oligonucleotide sequence (a), thereby obtaining an siRNA molecule for silencing the specific gene.
    Type: Application
    Filed: March 28, 2008
    Publication date: July 31, 2008
    Inventors: Alik Honigman, Amos Panet, Noam Levaot
  • Universal target sequences for siRNA gene silencing
    Publication number: 20070123485
    Abstract: The present invention provides methods for designing a sequence for efficient short interference RNA molecules. In particular, the present invention defines a universal target for siRNA derived from the consensus sequence of the polyadenylation signal in conjunction with unique sequences for gene silencing and inhibition of viral replication in a eukaryotic host cell. The present invention further provides methods for the treatment and prevention of diseases and disorders by silencing a gene of a virus, an oncogene, genes encoding transcription factors and many other diseases related genes.
    Type: Application
    Filed: October 12, 2006
    Publication date: May 31, 2007
    Inventors: Alik Honigman, Amos Panet, Noam Levaot